Johansson, P;
Almqvist, EG;
Wallin, A;
Johansson, J-O;
Andreasson, U;
Blennow, K;
Zetterberg, H;
(2017)
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.
PLOS ONE
, 12
(5)
, Article e0176760. 10.1371/journal.pone.0176760.
Preview |
Text
Zetterberg_Reduced cerebrospinal fluid concentration of interleukin-12 or 23 subunit p40 in patients with cognitive impairment_VoR.pdf - Published Version Download (1MB) | Preview |
Abstract
BACKGROUND: The role of inflammation in Alzheimer’s disease (AD) and other cognitive disorders is unclear. In a well-defined mono-center population, we measured cytokines and chemokines in paired serum and cerebrospinal fluid (CSF) samples. METHODS: Consecutive patients with AD (n = 30), stable mild cognitive impairment (SMCI, n = 11), other dementias (n = 11), and healthy controls (n = 18) were included. None of the subjects was treated with glucocorticoids, cholinesterase inhibitors, or non-steroidal anti-inflammatory drugs. Serum and CSF concentrations of interleukin-6 (IL-6), IL-8, IL-12/23 p40, IL-15, IL-16, vascular endothelial growth factor-A (VEGF-A), and three chemokines were measured using a multiplex panel. RESULTS: After correction for multiple comparisons, only CSF IL-12/23 p40 concentration differed significantly between the total patient group (n = 52) and controls (n = 18; p = 0.002). Further analyses showed that CSF IL-12/23 p40 concentration was decreased in all patient subgroups (AD, other dementias, and SMCI) compared to healthy controls (p < 0.01, p < 0.05, and p < 0.05, respectively). In the total study population (n = 70), CSF IL-12/23 p40 concentrations correlated positively with CSF concentrations of β-amyloid₁-₄₂ (Aβ₁-₄₂) and phosphorylated tau protein (P-tau) whereas in AD patients (n = 30), CSF IL-12/23 p40 only correlated positively with CSF P-Tau (r = 0.46, p = 0.01). CONCLUSIONS: Most cytokines and chemokines were similar in patients and controls, but CSF IL-12/23 subunit p40 concentration was decreased in patients with cognitive impairment, and correlated with markers of AD disease status. Further studies are needed to evaluate the role of CSF IL-12/23 p40 in other dementias and SMCI
| Type: | Article |
|---|---|
| Title: | Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1371/journal.pone.0176760 |
| Publisher version: | https://doi.org/10.1371/journal.pone.0176760 |
| Language: | English |
| Additional information: | © 2017 Johansson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). |
| Keywords: | Cerebrospinal fluid, Alzheimer's disease, Cognitive impairment, Cytokines, Dementia, Chemokines, Biomarkers, Vascular dementia |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10056839 |
Archive Staff Only
 |
View Item |
